It protects sensitive electrical equipment from unplanned power disturbances including harmonics, surge, sags, swells, ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Abstract: Power factor correction rectifiers/inverters with wide input-output voltage ranges are instrumental in applications with widely varying dc voltages such as photovoltaic inverters. Aiming at ...

Abstract: Distributed energy resources (DERs) are rocking the utilities’ business landscape. It calls for competitive market environments that incentivize DERs to form maximum operating efficiency.

Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024RUCONEST® third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024 ...

Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants. Minerva and the FDA have defined a path forward for roluperidone’s clinical ...

The perioperative period includes the preoperative, intraoperative, and postoperative phases of surgery. The preoperative phase starts with the decision to have surgery and ends when the patient ...

BREAKING: Shohei Ohtani Set to START Game 7 on Three Days Rest | Kiké Heads-Up Play SAVES Dodgers! To stream 12News on your phone, you need the 12News app.

A vaccine Moderna has long been developing for the world’s most common congenital infection has failed a Phase 3 trial. The biotechnology company said late Wednesday that the shot, dubbed mRNA-1647, ...

During the third quarter ended September 30, 2025, cash generated from operations of $198 million was used to invest in capital expenditures of $19 million, return $37 million to shareholders, through ...